Search - tctmd.com

Displaying 101 - 120 of 133

Sort: Relevancy | Date

News Industry News

Minneapolis Heart Institute Foundation Announces Schedule of Events at TCT Conference

October 18, 2012

News Industry News

Ebony® PTA .035 OTW – Additional lengths available

October 16, 2012

News Industry News

Medtronic Completes First-In-Man Study for Investigational Next-Generation Multi-Electrode Renal Denervation System in Patients with Treatment-Resistant Hypertension

October 03, 2012

News Industry News

Medtronic Initiates First Clinical Trial of the Symplicity™ Renal Denervation System for Treatment-Resistant Hypertension in Japan

October 01, 2012

News Industry News

Health-Economic Analysis Suggests Medtronic Symplicity™ Renal Denervation System Is Cost-Effective and May Reduce Cardiovascular Event Risks for Patients with Treatment-Resistant Hypertension

September 12, 2012

News Industry News

Medtronic Launches Resolute Integrity Coronary Stent System in Japan

August 28, 2012

News Industry News

PLC Systems' RenalGuard® Demonstrated At Major Latin American Cardiology Meeting

August 13, 2012

News Industry News

Preliminary results demonstrate that the novel delivery of dexamethasone via Mercator’s platform Micro-Infusion Catheter inhibits restenosis for at least 9 months in 10 patients treated for peripheral

July 16, 2012

News Industry News

PLC Systems Secures Additional Financing For US Clinical Trials And General Working Capital

July 02, 2012

News Industry News

PLC Announces Agreements To Distribute RenalGuard® In Central And South America, Turkey And The United Kingdom

May 30, 2012

News Industry News

FDA Advisory Committee Recommends Against Approval of Oral Anticoagulant XARELTO® to Reduce the Risk of Secondary Cardiovascular Events in Patients with Acute Coronary Syndrome

May 23, 2012

News Industry News

Renal Denervation Technology from St. Jude Medical Demonstrates Significant Reduction in Blood Pressure

May 16, 2012

News Industry News

Trial of Medtronic Symplicity™ Renal Denervation System Shows Significant Blood Pressure Reduction, With No Evidence of Renal Impairment, at Six Months Post Treatment

April 27, 2012

News Industry News

ReCor Medical discloses new data from clinical study of its PARADISE™ ultrasound transcatheter renal denervation system for treating resistant hypertension

April 09, 2012

News Industry News

ReCor Medical announces CE mark approval for its novel PARADISE™ ultrasound transcatheter renal denervation system

February 19, 2012

News Industry News

Clinical trial that compared transapical transcatheter aortic valve replacement to surgical aortic valve replacement

November 09, 2011

News Industry News

Survival data encouraging after TAVI in high-risk patients

November 06, 2011

News Industry News

Medtronic’s Unmatched Portfolio of Cardiovascular Devices Features Prominently on Program for TCT 2011

November 04, 2011

News Industry News

Medtronic Starts Landmark Study of Hypertension Treatment

October 26, 2011

News Industry News

PLC Systems Receives FDA Approval to Commence Pivotal Study of RenalGuard in the U.S.

October 14, 2011

Advertisement

Minneapolis Heart Institute Foundation Announces Schedule of Events at TCT Conference

Ebony® PTA .035 OTW – Additional lengths available

Medtronic Completes First-In-Man Study for Investigational Next-Generation Multi-Electrode Renal Denervation System in Patients with Treatment-Resistant Hypertension

Medtronic Initiates First Clinical Trial of the Symplicity™ Renal Denervation System for Treatment-Resistant Hypertension in Japan

Health-Economic Analysis Suggests Medtronic Symplicity™ Renal Denervation System Is Cost-Effective and May Reduce Cardiovascular Event Risks for Patients with Treatment-Resistant Hypertension

Medtronic Launches Resolute Integrity Coronary Stent System in Japan

PLC Systems' RenalGuard® Demonstrated At Major Latin American Cardiology Meeting

Preliminary results demonstrate that the novel delivery of dexamethasone via Mercator’s platform Micro-Infusion Catheter inhibits restenosis for at least 9 months in 10 patients treated for peripheral

PLC Systems Secures Additional Financing For US Clinical Trials And General Working Capital

PLC Announces Agreements To Distribute RenalGuard® In Central And South America, Turkey And The United Kingdom

FDA Advisory Committee Recommends Against Approval of Oral Anticoagulant XARELTO® to Reduce the Risk of Secondary Cardiovascular Events in Patients with Acute Coronary Syndrome

Renal Denervation Technology from St. Jude Medical Demonstrates Significant Reduction in Blood Pressure

Trial of Medtronic Symplicity™ Renal Denervation System Shows Significant Blood Pressure Reduction, With No Evidence of Renal Impairment, at Six Months Post Treatment

ReCor Medical discloses new data from clinical study of its PARADISE™ ultrasound transcatheter renal denervation system for treating resistant hypertension

ReCor Medical announces CE mark approval for its novel PARADISE™ ultrasound transcatheter renal denervation system

Clinical trial that compared transapical transcatheter aortic valve replacement to surgical aortic valve replacement

Survival data encouraging after TAVI in high-risk patients

Medtronic’s Unmatched Portfolio of Cardiovascular Devices Features Prominently on Program for TCT 2011

Medtronic Starts Landmark Study of Hypertension Treatment

PLC Systems Receives FDA Approval to Commence Pivotal Study of RenalGuard in the U.S.

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content